Terms: = Liver cancer AND FOXL2, BPES, 668, ENSG00000183770, P58012, PFRK, POF3, PINTO, BPES1 AND Prognosis
32 results:
1. Applying image features of proximal paracancerous tissues in predicting prognosis of patients with hepatocellular carcinoma.
Lin S; Yong J; Zhang L; Chen X; Qiao L; Pan W; Yang Y; Zhao H
Comput Biol Med; 2024 May; 173():108365. PubMed ID: 38537563
[TBL] [Abstract] [Full Text] [Related]
2. Prediction of survival and analysis of prognostic factors for patients with AFP negative hepatocellular carcinoma: a population-based study.
Liu C; Li Z; Zhang Z; Li J; Xu C; Jia Y; Zhang C; Yang W; Wang W; Wang X; Liang K; Peng L; Wang J
BMC Gastroenterol; 2024 Mar; 24(1):93. PubMed ID: 38438972
[TBL] [Abstract] [Full Text] [Related]
3. A novel nomogram based on the hematological prognosis risk scoring system can predict the overall survival of patients with hepatocellular carcinoma.
Lei K; Deng Z; Wang J; Wang H; Hu R; Li Y; Wang X; Xu J; You K; Liu Z
J Cancer Res Clin Oncol; 2023 Nov; 149(16):14631-14640. PubMed ID: 37584710
[TBL] [Abstract] [Full Text] [Related]
4. Cytochrome P2E1 (CYP2E1) Gene Polymorphism as a Potential Prognostic Biomarker in Colorectal cancer.
Moghadas A; Karbalaie Niya MH; Zamani F; Moazzami M; Farhang F; Ajdarkosh H; Khoonsari M; Faraji A; Panahi M; Emtiazi N; Safarnezhad Tameshkel F; Nikkhah M
Asian Pac J Cancer Prev; 2023 Jul; 24(7):2239-2244. PubMed ID: 37505752
[TBL] [Abstract] [Full Text] [Related]
5. Risk Factors of Positive Resection Margin in Hepatectomy for Resectable Ruptured Hepatocellular Carcinoma: Risk Prediction and prognosis.
Xia F; Zhang Q; Zheng J; Huang Z; Ndhlovu E; Gao H
J Gastrointest Surg; 2023 Jul; 27(7):1400-1411. PubMed ID: 37095336
[TBL] [Abstract] [Full Text] [Related]
6. LiSNet: An artificial intelligence -based tool for liver imaging staging of hepatocellular carcinoma aggressiveness.
Sun SW; Xu X; Liu QP; Chen JN; Zhu FP; Liu XS; Zhang YD; Wang J
Med Phys; 2022 Nov; 49(11):6903-6913. PubMed ID: 36134900
[TBL] [Abstract] [Full Text] [Related]
7. The cancers-Specific Survival of Metastatic Pulmonary Carcinoids and Sites of Distant Metastasis: A Population-Based Study.
Zhang J; Yu Q; He Y; Hu T; Chen K; Yang Z; Zhang X; Cheng D; He Z
Technol Cancer Res Treat; 2021; 20():15330338211036528. PubMed ID: 34378452
[TBL] [Abstract] [Full Text] [Related]
8. Impact of Tumor Burden Score on Conditional Survival after Curative-Intent Resection for Hepatocellular Carcinoma: A Multi-Institutional Analysis.
Elfadaly AN; Tsilimigras DI; Hyer JM; Paro A; Bagante F; Ratti F; Marques HP; Soubrane O; Lam V; Poultsides GA; Popescu I; Alexandrescu S; Martel G; Workneh A; Guglielmi A; Hugh T; Aldrighetti L; Endo I; Pawlik TM
World J Surg; 2021 Nov; 45(11):3438-3448. PubMed ID: 34341844
[TBL] [Abstract] [Full Text] [Related]
9. Portal Vein Irradiation Stent Plus Chemoembolization versus External Radiotherapy Plus Chemoembolization in Hepatocellular Carcinoma with Portal Vein Tumour Thrombus: A Retrospective Study.
Tan Z; Lu J; Zhu G; Chen L; Wang Y; Zhang Q; Pan T; Wang J; Guo J; Teng G
Cardiovasc Intervent Radiol; 2021 Sep; 44(9):1414-1422. PubMed ID: 34131776
[TBL] [Abstract] [Full Text] [Related]
10. The value of the signal intensity of peritumoral tissue on Gd-EOB-DTPA dynamic enhanced MRI in assessment of microvascular invasion and pathological grade of hepatocellular carcinoma.
Wang LL; Li JF; Lei JQ; Guo SL; Li JK; Xu YS; Dou Y
Medicine (Baltimore); 2021 May; 100(20):e25804. PubMed ID: 34011043
[TBL] [Abstract] [Full Text] [Related]
11. LINC00668 cooperated with HuR dependent upregulation of PKN2 to facilitate gastric cancer metastasis.
Li J; Dong W; Jiang Q; Zhang F; Dong H
Cancer Biol Ther; 2021 Apr; 22(4):311-323. PubMed ID: 33879018
[TBL] [Abstract] [Full Text] [Related]
12. Identifying the Prognostic Risk Factors of Synaptojanin 2 and Its Underlying Perturbations Pathways in Hepatocellular Carcinoma.
Zhang R; Mo WJ; Huang LS; Chen JT; Wu WZ; He WY; Feng ZB
Bioengineered; 2021 Dec; 12(1):855-874. PubMed ID: 33641617
[TBL] [Abstract] [Full Text] [Related]
13. Survival in untreated hepatocellular carcinoma: A national cohort study.
Kim YA; Kang D; Moon H; Sinn D; Kang M; Woo SM; Chang YJ; Park B; Kong SY; Guallar E; Shin SY; Gwak G; Back JH; Lee ES; Cho J
PLoS One; 2021; 16(2):e0246143. PubMed ID: 33539397
[TBL] [Abstract] [Full Text] [Related]
14. Clinicopathologic and MRI features of combined hepatocellular-cholangiocarcinoma in patients with or without cirrhosis.
Yoon J; Hwang JA; Lee S; Lee JE; Ha SY; Park YN
Liver Int; 2021 Jul; 41(7):1641-1651. PubMed ID: 33503328
[TBL] [Abstract] [Full Text] [Related]
15. Prognostic Significance of Pretreatment 18F-FDG PET/CT Volumetric Parameters in Patients With Colorectal liver Metastasis: A Systematic Review and Meta-analysis.
Kim YI; Lee HS; Choi JY
Clin Nucl Med; 2021 Mar; 46(3):206-213. PubMed ID: 33443946
[TBL] [Abstract] [Full Text] [Related]
16. Hepatobiliary phase of gadoxetic acid-enhanced MRI in patients with HCC: prognostic features before resection, ablation, or TACE.
Bae JS; Kim JH; Lee DH; Kim JH; Han JK
Eur Radiol; 2021 Jun; 31(6):3627-3637. PubMed ID: 33211146
[TBL] [Abstract] [Full Text] [Related]
17. [Epidemiological and anatomopathological profile of breast cancer at the Ibn Rochd University Hospital, Casablanca].
Fouhi ME; Benider A; Gaëtan KZA; Mesfioui A
Pan Afr Med J; 2020; 37():41. PubMed ID: 33209168
[TBL] [Abstract] [Full Text] [Related]
18. The prognostic value of aspartate aminotransferase-to-lymphocyte ratio index in early-stage hepatocellular carcinoma after hepatectomy: A propensity-score matched analysis.
Chen Y; He C; Wen T; Yan L; Yang J
Asia Pac J Clin Oncol; 2021 Oct; 17(5):e238-e248. PubMed ID: 33124200
[TBL] [Abstract] [Full Text] [Related]
19. Development and validation of a prognostic model based on the albumin-to-fibrinogen ratio (AFR) and gamma-glutamyl transpeptidase-to-platelet ratio (GPR) in hepatocellular carcinoma patients.
Zhang J; Wang T; Xu L; Wang P; Zhang M; Xu M
Clin Chim Acta; 2020 Dec; 511():107-116. PubMed ID: 33035501
[TBL] [Abstract] [Full Text] [Related]
20. Simplified nomograms based on platelet-associated models for survival prediction in Asian hepatocellular carcinoma patients after surgery.
Gu J; Zhang X; Wang Z; Cui R; Zhang J; Jia Y; Miao R; Fan H; Wang H; Li Y; Zhang J; Liu C; Qu K
Surg Oncol; 2019 Sep; 30():131-138. PubMed ID: 31500777
[TBL] [Abstract] [Full Text] [Related]
[Next]
